Steele Creek Capital Corp

2024 Q3 Form 10-Q Financial Statement

#000121390024067020 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $15.84M $6.525M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $193.9M $153.5M
YoY Change 26.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $132.4M $99.69M
YoY Change 32.85%
SHAREHOLDERS EQUITY
Retained Earnings -$6.141M -$8.363M
YoY Change -26.57%
Common Stock $67.60M $62.13M
YoY Change 8.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $61.46M $53.77M
YoY Change
Total Liabilities & Shareholders Equity $193.9M $153.5M
YoY Change 26.35%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.25
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6352 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6360 shares
CY2023Q2 us-gaap Other Income
OtherIncome
usd
us-gaap Other Income
OtherIncome
usd
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.30
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.41
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.85
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
814-01351
dei Entity Registrant Name
EntityRegistrantName
STEELE CREEK CAPITAL CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1327288
dei Entity Address Address Line1
EntityAddressAddressLine1
210 S. College Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1690
dei Entity Address City Or Town
EntityAddressCityOrTown
Charlotte
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
28244
dei City Area Code
CityAreaCode
(704)
dei Local Phone Number
LocalPhoneNumber
343-6011
dei No Trading Symbol Flag
NoTradingSymbolFlag
true
dei Security12g Title
Security12gTitle
Common Stock, par value $0.001 per share
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5763657 shares
CY2024Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
141347000 usd
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
142333000 usd
CY2024Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
138333000 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
138533000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15837000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9325000 usd
CY2024Q2 us-gaap Receivable Investment Sale
ReceivableInvestmentSale
38812000 usd
CY2023Q4 us-gaap Receivable Investment Sale
ReceivableInvestmentSale
32451000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
241000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
339000 usd
CY2024Q2 us-gaap Interest Receivable
InterestReceivable
672000 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
744000 usd
CY2024Q2 us-gaap Assets
Assets
193895000 usd
CY2023Q4 us-gaap Assets
Assets
181392000 usd
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
89186000 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
86316000 usd
CY2024Q2 us-gaap Payable Investment Purchase
PayableInvestmentPurchase
41465000 usd
CY2023Q4 us-gaap Payable Investment Purchase
PayableInvestmentPurchase
30188000 usd
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
344000 usd
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
51000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
50000 usd
CY2023Q4 us-gaap Incentive Fee Payable
IncentiveFeePayable
80000 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
504000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
475000 usd
CY2024Q2 us-gaap Distribution Payable
DistributionPayable
1230000 usd
CY2023Q4 us-gaap Distribution Payable
DistributionPayable
2081000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
132436000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
119534000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6388582 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6388582 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6388582 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6388582 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6370722 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6370722 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
6000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6000 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
67594000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
67420000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6141000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5568000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
61459000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
61858000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
193895000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
181392000 usd
CY2024Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.62
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.71
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3387000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
6836000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3055000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
6254000 usd
CY2024Q2 us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
74000 usd
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
78000 usd
CY2023Q2 us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
200000 usd
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
218000 usd
CY2024Q2 us-gaap Other Income
OtherIncome
51000 usd
us-gaap Other Income
OtherIncome
59000 usd
CY2024Q2 us-gaap Investment Income Net
InvestmentIncomeNet
3512000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
6973000 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
3255000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
6472000 usd
CY2024Q2 us-gaap Management Fee Expense
ManagementFeeExpense
470000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
925000 usd
CY2023Q2 us-gaap Management Fee Expense
ManagementFeeExpense
375000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
747000 usd
CY2024Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1559000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
3044000 usd
CY2023Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1334000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
2636000 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
110000 usd
us-gaap Professional Fees
ProfessionalFees
209000 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
95000 usd
us-gaap Professional Fees
ProfessionalFees
190000 usd
us-gaap Incentive Fee Expense
IncentiveFeeExpense
56000 usd
us-gaap Incentive Fee Expense
IncentiveFeeExpense
76000 usd
CY2024Q2 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
90000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
150000 usd
CY2023Q2 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
57000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
115000 usd
CY2024Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
20000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
40000 usd
CY2023Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
20000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
40000 usd
CY2024Q2 us-gaap Custody Fees
CustodyFees
11000 usd
us-gaap Custody Fees
CustodyFees
23000 usd
CY2023Q2 us-gaap Custody Fees
CustodyFees
11000 usd
us-gaap Custody Fees
CustodyFees
23000 usd
CY2024Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
211000 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
370000 usd
CY2023Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
191000 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
310000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2471000 usd
us-gaap Operating Expenses
OperatingExpenses
4817000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2083000 usd
us-gaap Operating Expenses
OperatingExpenses
4137000 usd
CY2024Q2 ck0000181782 Management Fees Waived
ManagementFeesWaived
-470000 usd
ck0000181782 Management Fees Waived
ManagementFeesWaived
-576000 usd
CY2023Q2 ck0000181782 Management Fees Waived
ManagementFeesWaived
-375000 usd
ck0000181782 Management Fees Waived
ManagementFeesWaived
-427000 usd
ck0000181782 Incentive Fees Waived
IncentiveFeesWaived
-8000 usd
CY2024Q2 us-gaap Investment Company Expense After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement
2001000 usd
us-gaap Investment Company Expense After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement
4241000 usd
CY2023Q2 us-gaap Investment Company Expense After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement
1708000 usd
us-gaap Investment Company Expense After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement
3702000 usd
CY2024Q2 us-gaap Net Investment Income
NetInvestmentIncome
1511000 usd
us-gaap Net Investment Income
NetInvestmentIncome
2732000 usd
CY2023Q2 us-gaap Net Investment Income
NetInvestmentIncome
1547000 usd
us-gaap Net Investment Income
NetInvestmentIncome
2770000 usd
CY2024Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1642000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1629000 usd
CY2023Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1001000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1419000 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1716000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
787000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1795000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3461000 usd
CY2024Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
74000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-842000 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
794000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
2042000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1585000 usd
us-gaap Net Income Loss
NetIncomeLoss
1890000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2341000 usd
us-gaap Net Income Loss
NetIncomeLoss
4812000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.25
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.3
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.41
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.85
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6360 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6352 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5673 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5683 shares
CY2024Q2 us-gaap Net Investment Income
NetInvestmentIncome
1511000 usd
us-gaap Net Investment Income
NetInvestmentIncome
2732000 usd
CY2023Q2 us-gaap Net Investment Income
NetInvestmentIncome
1547000 usd
us-gaap Net Investment Income
NetInvestmentIncome
2770000 usd
CY2024Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1642000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1629000 usd
CY2023Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1001000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1419000 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1716000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
787000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1795000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3461000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1585000 usd
us-gaap Net Income Loss
NetIncomeLoss
1890000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2341000 usd
us-gaap Net Income Loss
NetIncomeLoss
4812000 usd
CY2024Q2 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
1230000 usd
us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
2463000 usd
CY2023Q2 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
1059000 usd
us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
2126000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
556000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1269000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1136000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1751000 usd
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
571000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1095000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1046000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1046000 usd
CY2024Q2 us-gaap Investment Company Increase Decrease From Share Transaction
InvestmentCompanyIncreaseDecreaseFromShareTransaction
-15000 usd
us-gaap Investment Company Increase Decrease From Share Transaction
InvestmentCompanyIncreaseDecreaseFromShareTransaction
174000 usd
CY2023Q2 us-gaap Investment Company Increase Decrease From Share Transaction
InvestmentCompanyIncreaseDecreaseFromShareTransaction
90000 usd
us-gaap Investment Company Increase Decrease From Share Transaction
InvestmentCompanyIncreaseDecreaseFromShareTransaction
705000 usd
CY2024Q2 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
340000 usd
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-399000 usd
CY2023Q2 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
1372000 usd
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
3391000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
61119000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
61858000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
52394000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
50375000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
61459000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
61459000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
53766000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
53766000 usd
CY2024Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
58 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
132 shares
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
124 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
191 shares
CY2024Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
60000 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
114000 shares
CY2023Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
114000 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
114000 shares
CY2024Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
6391 shares
CY2023Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
6371 shares
CY2023Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
5710 shares
CY2022Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
5643 shares
CY2024Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
6389 shares
CY2024Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
6389 shares
CY2023Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
5720 shares
CY2023Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
5720 shares
us-gaap Net Income Loss
NetIncomeLoss
1890000 usd
us-gaap Net Income Loss
NetIncomeLoss
4812000 usd
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
78000 usd
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
218000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
136000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
208000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1629000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1419000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
787000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3461000 usd
us-gaap Increase Decrease In Receivable For Investment Sold
IncreaseDecreaseInReceivableForInvestmentSold
6361000 usd
us-gaap Increase Decrease In Receivable For Investment Sold
IncreaseDecreaseInReceivableForInvestmentSold
-1425000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-98000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-54000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-72000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
271000 usd
us-gaap Increase Decrease In Payable For Investment Purchased
IncreaseDecreaseInPayableForInvestmentPurchased
11277000 usd
us-gaap Increase Decrease In Payable For Investment Purchased
IncreaseDecreaseInPayableForInvestmentPurchased
4263000 usd
us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
-344000 usd
us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
-319000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-13000 usd
us-gaap Increase Decrease In Incentive Fee Payable
IncreaseDecreaseInIncentiveFeePayable
-80000 usd
us-gaap Increase Decrease In Incentive Fee Payable
IncreaseDecreaseInIncentiveFeePayable
-24000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
29000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-14000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6782000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8251000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1269000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1751000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1095000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1046000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
7870000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1400000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
5000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
6100000 usd
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
3314000 usd
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
2424000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-270000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6419000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6512000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1832000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9325000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4693000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15837000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6525000 usd
us-gaap Interest Paid Net
InterestPaidNet
3042000 usd
us-gaap Interest Paid Net
InterestPaidNet
2649000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates -</i></b> The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Investment Advisor to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from such estimates included in the consolidated financial statements. </p>
ck0000181782 Investment Of Voting Percentage
InvestmentOfVotingPercentage
0.25 pure
us-gaap Management And Service Fees Base Rate
ManagementAndServiceFeesBaseRate
0.01 pure
CY2024Q2 us-gaap Management Fee Expense
ManagementFeeExpense
470000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
925000 usd
CY2024Q2 ck0000181782 Net Management Fees
NetManagementFees
0 usd
ck0000181782 Net Management Fees
NetManagementFees
349000 usd
CY2023Q2 us-gaap Management Fee Expense
ManagementFeeExpense
375000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
747000 usd
CY2023Q2 ck0000181782 Net Management Fees
NetManagementFees
0 usd
ck0000181782 Net Management Fees
NetManagementFees
320000 usd
us-gaap Management And Service Fees Incentive Rate
ManagementAndServiceFeesIncentiveRate
0.15 pure
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.015 pure
CY2024 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.06 pure
us-gaap Investment Company Total Return Gain On Investment In Violation
InvestmentCompanyTotalReturnGainOnInvestmentInViolation
0.15 pure
us-gaap Incentive Fee Expense
IncentiveFeeExpense
56000 usd
us-gaap Incentive Fee Expense
IncentiveFeeExpense
76000 usd
CY2021Q1 ck0000181782 Targeted Annual Distribution Percentage Of Net Asset Value Per Share Percentage
TargetedAnnualDistributionPercentageOfNetAssetValuePerSharePercentage
0.06 pure
CY2024Q2 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
121000 usd
us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
227000 usd
CY2023Q2 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
53000 usd
us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
105000 usd
ck0000181782 Additional Management Fee Expense
AdditionalManagementFeeExpense
349000 usd
CY2024Q2 ck0000181782 Additional Management Fee Expense
AdditionalManagementFeeExpense
349000 usd
ck0000181782 Additional Management Fee Expense
AdditionalManagementFeeExpense
322000 usd
CY2023Q2 ck0000181782 Additional Management Fee Expense
AdditionalManagementFeeExpense
322000 usd
ck0000181782 Related Party Ownership Percentage
RelatedPartyOwnershipPercentage
0.38 pure
CY2023 ck0000181782 Related Party Ownership Percentage
RelatedPartyOwnershipPercentage
0.38 pure
CY2024Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
20000 usd
CY2023Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
20000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
40000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
40000 usd
CY2024Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
138333000 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
138533000 usd
CY2024Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
184000 usd
CY2024Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-853000 usd
CY2024Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
1069000 usd
CY2024Q2 ck0000181782 Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Dispositions
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationDispositions
-378000 usd
CY2024Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
22000 usd
CY2023Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
1473000 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-853000 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
1045000 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3
-1265000 usd
ck0000181782 Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Dispositions
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationDispositions
-378000 usd
CY2024Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
22000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1585000 usd
us-gaap Net Income Loss
NetIncomeLoss
1890000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6360 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6352 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.25
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.3
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2341000 usd
us-gaap Net Income Loss
NetIncomeLoss
4812000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5673 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5683 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.41
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.85
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
556000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1269000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1136000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1751000 usd
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6388582 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6370722 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Line Of Credit Facility Maximum Amount Outstanding During Period
LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
45000000 usd
us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
25000 usd
CY2024Q2 ck0000181782 Structuring Fee Rate
StructuringFeeRate
0.0025 pure
CY2021Q2 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.007 pure
CY2021Q2 us-gaap Line Of Credit Facility Revolving Credit Conversion To Term Loan Description
LineOfCreditFacilityRevolvingCreditConversionToTermLoanDescription
Material amendments included the revolving period being extended 36 months, from 12 months to 48 months and the interest rate being reduced from LIBOR plus 175 basis points to LIBOR plus 140 basis points.
CY2021Q4 us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.60 pure
CY2024Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1559000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
3044000 usd
CY2024Q2 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
88101000 usd
us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
85777000 usd
CY2023Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1334000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
2636000 usd
CY2023Q2 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
79907000 usd
us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
81403000 usd
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.71
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
8.93
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
10.9
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
10.76
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.43
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.49
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.29
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.06
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.26
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.25
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.03
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.46
ck0000181782 Net Change In Unrealizeddepreciation Appreciationin
NetChangeInUnrealizeddepreciationAppreciationin
-0.12
ck0000181782 Net Change In Unrealizeddepreciation Appreciationin
NetChangeInUnrealizeddepreciationAppreciationin
-0.61
ck0000181782 Net Change In Unrealizeddepreciation Appreciationin
NetChangeInUnrealizeddepreciationAppreciationin
1.74
ck0000181782 Net Change In Unrealizeddepreciation Appreciationin
NetChangeInUnrealizeddepreciationAppreciationin
-0.02
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.29
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.85
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-1.42
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.54
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.39
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.38
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.33
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.33
ck0000181782 Investment Company Other Per Share
InvestmentCompanyOtherPerShare
0.01
ck0000181782 Investment Company Other Per Share
InvestmentCompanyOtherPerShare
0.06
ck0000181782 Investment Company Other Per Share
InvestmentCompanyOtherPerShare
0.06
CY2024Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.62
CY2023Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.4
CY2022Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.21
CY2021Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.03
CY2024Q2 us-gaap Assets Net
AssetsNet
61459000 usd
CY2023Q2 us-gaap Assets Net
AssetsNet
53766000 usd
CY2022Q2 us-gaap Assets Net
AssetsNet
48587000 usd
CY2021Q2 us-gaap Assets Net
AssetsNet
41708000 usd
CY2024Q2 us-gaap Shares Outstanding
SharesOutstanding
6388582 shares
CY2023Q2 us-gaap Shares Outstanding
SharesOutstanding
5720234 shares
CY2022Q2 us-gaap Shares Outstanding
SharesOutstanding
5274748 shares
CY2021Q2 us-gaap Shares Outstanding
SharesOutstanding
3782214 shares
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0311 pure
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.097 pure
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.129 pure
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0562 pure
us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.1567 pure
us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.1584 pure
us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.0964 pure
us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.1164 pure
us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.1473 pure
us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.15 pure
us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.0867 pure
us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.1024 pure
us-gaap Investment Company Incentive Allocation To Average Net Assets
InvestmentCompanyIncentiveAllocationToAverageNetAssets
0.0808 pure
us-gaap Investment Company Incentive Allocation To Average Net Assets
InvestmentCompanyIncentiveAllocationToAverageNetAssets
0.1001 pure
us-gaap Investment Company Incentive Allocation To Average Net Assets
InvestmentCompanyIncentiveAllocationToAverageNetAssets
0.0469 pure
us-gaap Investment Company Incentive Allocation To Average Net Assets
InvestmentCompanyIncentiveAllocationToAverageNetAssets
0.0074 pure
us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
1.237 pure
us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.679 pure
us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.71 pure
us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
3.249 pure
CY2024Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
4420 shares
CY2024Q3 ck0000181782 Offering Price
OfferingPrice
43000 usd
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 ck0000181782 Incentive Fees Waived
IncentiveFeesWaived
usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5673 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5683 shares
CY2024Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3
usd
CY2024Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Purchases
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchases
usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Purchases
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchases
usd
ck0000181782 Investment Company Other Per Share
InvestmentCompanyOtherPerShare
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001817825

Files In Submission

Name View Source Status
0001213900-24-067020-index-headers.html Edgar Link pending
0001213900-24-067020-index.html Edgar Link pending
0001213900-24-067020.txt Edgar Link pending
0001213900-24-067020-xbrl.zip Edgar Link pending
ck0000181782-20240630.xsd Edgar Link pending
ea0210112-10q_steele.htm Edgar Link pending
ea021011201ex31-1_steele.htm Edgar Link pending
ea021011201ex31-2_steele.htm Edgar Link pending
ea021011201ex32-1_steele.htm Edgar Link pending
ea021011201ex32-2_steele.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
ck0000181782-20240630_def.xml Edgar Link unprocessable
ck0000181782-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0210112-10q_steele_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ck0000181782-20240630_cal.xml Edgar Link unprocessable
ck0000181782-20240630_lab.xml Edgar Link unprocessable